{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30650453", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "10"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1055/a-0824-1316"], "Journal": {"ISSN": "1439-0221", "JournalIssue": {"Volume": "85", "Issue": "5", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Triterpenoids from Hibiscus sabdariffa L.\u00a0with PPAR\u03b4/\u03b3 Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.", "Pagination": {"StartPage": "412", "EndPage": "423", "MedlinePgn": "412-423"}, "Abstract": {"AbstractText": ["<i>Hibiscus sabdariffa</i> is a medicinal plant consumed as a diuretic and anti-obesity remedy. Several pharmacological studies have shown its beneficial effects in metabolism. Peroxisome proliferator-activated receptors <i>\u03b4</i> and <i>\u03b3</i> may play a role in the actions of <i>H. sabdariffa.</i> These nuclear receptors regulate lipid and glucose metabolism and are therapeutic targets for type 2 diabetes. This research aimed to perform a phytochemical study guided by a bioassay from <i>H. sabdariffa</i> to identify compounds with peroxisome proliferator-activated receptor <i>\u03b4</i> and peroxisome proliferator-activated receptor <i>\u03b3</i> agonist activity, supported by messenger ribonucleic acid expression, molecular docking, lipid accumulation, and an antihyperglycemic effect. An oral glucose tolerance test in mice with the aqueous extract of <i>H. sabdariffa</i> and the dichloromethane extract of <i>H.\u00a0sabdariffa</i> was performed. The dichloromethane extract of <i>H. sabdariffa</i> exhibited an antihyperglycemic effect. The dichloromethane extract of <i>H. sabdariffa</i> was fractioned, and four fractions were evaluated in 3T3-L1 adipocytes on peroxisome proliferator-activated receptor <i>\u03b4</i>, peroxisome proliferator-activated receptor <i>\u03b3</i>, fatty acid transporter protein, and glucose transporter type 4 messenger ribonucleic acid expression. Fraction F3 exhibited peroxisome proliferator-activated receptor <i>\u03b4</i>/<i>\u03b3</i> dual agonist activity, and a further fractionation yielded two subfractions, F3-1 and F3-2, which also increased peroxisome proliferator-activated receptor <i>\u03b4</i> and peroxisome proliferator-activated receptor <i>\u03b3</i> expression. Subfractions were analyzed by GC/MS. The main compounds identified in F3-1 were linoleic acid, oleic acid, and palmitic acid, while in F3-2, the main compounds identified were <i>\u03b1</i>-amyrin and lupeol. These molecules were subjected to molecular docking analysis. <i>\u03b1</i>-Amyrin and lupeol showed the highest affinity. Moreover, both produced an increase in peroxisome proliferator-activated receptor <i>\u03b4</i>, peroxisome proliferator-activated receptor <i>\u03b3</i>, fatty acid transporter protein, and glucose transporter type 4 expression. Additionally, <i>\u03b1</i>-amyrin and lupeol decreased lipid accumulation in 3T3-L1 adipocytes and blood glucose in mice. Until now, <i>\u03b1</i>-amyrin and lupeol have not been reported with activity on peroxisome proliferator-activated receptors. This study provides evidence that <i>\u03b1</i>-amyrin and lupeol possess antidiabetic effects through a peroxisome proliferator-activated receptor <i>\u03b4</i>/<i>\u03b3</i> dual agonist action."], "CopyrightInformation": "Georg Thieme Verlag KG Stuttgart \u00b7 New York."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Posgrado en Biolog\u00eda Experimental, Universidad Aut\u00f3noma Metropolitana-Iztapalapa, Ciudad de M\u00e9xico, M\u00e9xico."}], "LastName": "Giacoman-Mart\u00ednez", "ForeName": "Abraham", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Farmacolog\u00eda, Departamento de Ciencias de la Salud, Divisi\u00f3n de Ciencias Biol\u00f3gicas y de la Salud, Universidad Aut\u00f3noma Metropolitana-Iztapalapa, Ciudad de M\u00e9xico, M\u00e9xico."}], "LastName": "Alarc\u00f3n-Aguilar", "ForeName": "Francisco J", "Initials": "FJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Fitoqu\u00edmica Farmacol\u00f3gica, Centro de Investigaci\u00f3n Biom\u00e9dica del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelos, M\u00e9xico."}], "LastName": "Zamilpa", "ForeName": "Alejandro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CONACyT, IPICYT/Consorcio de Investigaci\u00f3n, Innovaci\u00f3n y Desarrollo para las Zonas \u00c1ridas, San Luis Potos\u00ed, M\u00e9xico."}], "LastName": "Hidalgo-Figueroa", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Farmacia, Universidad Aut\u00f3noma del Estado de Morelos, Cuernavaca, Morelos, M\u00e9xico."}], "LastName": "Navarrete-V\u00e1zquez", "ForeName": "Gabriel", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unidad de Investigaci\u00f3n M\u00e9dica en Bioqu\u00edmica, Hospital de Especialidades, Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de M\u00e9xico, M\u00e9xico."}], "LastName": "Garc\u00eda-Macedo", "ForeName": "Rebeca", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Farmacolog\u00eda, Departamento de Ciencias de la Salud, Divisi\u00f3n de Ciencias Biol\u00f3gicas y de la Salud, Universidad Aut\u00f3noma Metropolitana-Iztapalapa, Ciudad de M\u00e9xico, M\u00e9xico."}], "LastName": "Rom\u00e1n-Ramos", "ForeName": "Rub\u00e9n", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio de Farmacolog\u00eda, Departamento de Ciencias de la Salud, Divisi\u00f3n de Ciencias Biol\u00f3gicas y de la Salud, Universidad Aut\u00f3noma Metropolitana-Iztapalapa, Ciudad de M\u00e9xico, M\u00e9xico."}], "LastName": "Almanza-P\u00e9rez", "ForeName": "Julio C", "Initials": "JC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucose Transporter Type 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR delta"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "KM8353IPSO", "NameOfSubstance": "beta-amyrin"}, {"RegistryNumber": "O268W13H3O", "NameOfSubstance": "lupeol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "3T3-L1 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Adipocytes"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["genetics"], "DescriptorName": "Glucose Transporter Type 4"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hibiscus"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": ["agonists"], "DescriptorName": "PPAR delta"}, {"QualifierName": ["agonists"], "DescriptorName": "PPAR gamma"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Triterpenes"}], "CoiStatement": "The authors declare that there is no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "1", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "17", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30650453", "10.1055/a-0824-1316"]}}]}